← SynDRA
BUFEXAMAC
SynDRA canonical compound SYN0003773 — structure-anchored drug synonym record
| Clinical phase | Withdrawn |
|---|
| Primary target(s) | HDAC10 | HDAC6 |
|---|
| Mechanism of action | cyclooxygenase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- HDAC10 INHIBITOR
- HDAC6 INHIBITOR
- cyclooxygenase inhibitor
Drug classes
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Peripheral Nervous System Agents
- Sensory System Agents
ATC classes
- M01A · ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
- M02A · TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
Cross-references
Synonyms
- bufexamic acid
- feximac
- mofenar
- parfenal
- Bufexamaco
- CP-1044-J3
- NSC-758153
- Duradermal
- Parfenac
- Bufexamic acid
- 2-(4-Butoxyphenyl)-N-hydroxyacetamide
- Parfenal
- Feximac
- Mofenar
- Malipuran
- Droxaryl
- Bufexamacum
- Flogicid
- Paraderm
- Norfemac
- Anderm
- 4-Butoxy-N-hydroxybenzeneacetamide
- p-Butoxyphenylacetohydroxamic acid
- 4-Butoxyphenylacetohydroxamic acid
- Flogocid N plastigel
- Acide p-butoxyphenylacethydroxamique
- 2-(p-Butoxyphenyl)-acetohydroxamic acid
- Bufessamac [DCIT]
- Bufexamacum [INN-Latin]
- Bufexamaco [INN-Spanish]
- CP 1044 J3
- UNII-4T3C38J78L
- Benzeneacetamide, 4-butoxy-N-hyd
- NSC 758153
- CHEBI:31317
- 4T3C38J78L
- DTXCID5025368
- Bufexamacratiopharm
Look up BUFEXAMAC in the interactive SynDRA portal →